Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients
ClinicalTrials.gov study NCT06402981. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative
ClinicalTrials.gov study NCT07034391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer
ClinicalTrials.gov study NCT06462053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects
ClinicalTrials.gov study NCT04464733. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) Targeting the Right Globus Pallidus Internus (GPi) for Motor Symptoms in Patients With PD
ClinicalTrials.gov study NCT06931483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced
ClinicalTrials.gov study NCT06772454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
ClinicalTrials.gov study NCT06190275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
ClinicalTrials.gov study NCT07284992. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT06556199. IPD Sharing: NO. Countries: 1. Publications: 0.
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.
ClinicalTrials.gov study NCT01664221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
ClinicalTrials.gov study NCT07049926. IPD Sharing: YES. Countries: 7. Publications: 0.
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT04040491. IPD Sharing: NO. Countries: 1. Publications: 0.
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
ClinicalTrials.gov study NCT06107374. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
ClinicalTrials.gov study NCT03540303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects
ClinicalTrials.gov study NCT02914353. IPD Sharing: NO. Countries: 1. Publications: 0.
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
ClinicalTrials.gov study NCT06923345. IPD Sharing: NO. Countries: 1. Publications: 0.
Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects
ClinicalTrials.gov study NCT02643901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical
ClinicalTrials.gov study NCT06620822. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
ClinicalTrials.gov study NCT06029829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC
ClinicalTrials.gov study NCT04886401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.